Skip to content

Drug interactions

Lansoprazole + Lorlatinib

Severity: Minor

Lansoprazole and Lorlatinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lorlatinib is a moderate CYP3A inducer and may lower lansoprazole concentrations, potentially reducing acid suppression. The effect is likely modest because lansoprazole is also cleared by CYP2C19.

What this interaction means in plain words

Lansoprazole and Lorlatinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Lansoprazole belongs to Gastrointestinal Tract; Lorlatinib belongs to Oncology.

Evidence level: Low

Why it happens

Lorlatinib induces CYP3A4, increasing the metabolism of lansoprazole.

What to do

Monitor for reduced control of reflux or ulcer symptoms and increase the PPI dose if symptoms persist.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lansoprazole and Lorlatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Lansoprazole with Lorlatinib?

MediHelp rates the interaction as minor. Lansoprazole and Lorlatinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Lorlatinib is a moderate CYP3A inducer and may lower lansoprazole concentrations, potentially reducing acid suppression. The effect is likely modest because lansoprazole is also cleared by CYP2C19.

How serious is the interaction between Lansoprazole and Lorlatinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for reduced control of reflux or ulcer symptoms and increase the PPI dose if symptoms persist.

What other medicines interact with Lansoprazole?

MediHelp also lists interactions of Lansoprazole with, for example, Mavacamten, Rilpivirine, Acalabrutinib. The full list is on the Lansoprazole page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in